CN Stock MarketDetailed Quotes

301263 Guangdong Taienkang Pharmaceutical

Watchlist

14.54
-0.05-0.34%

Noon Break Nov 4 11:30 CST

6.19BMarket Cap45.87P/E (TTM)

Guangdong Taienkang Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Guangdong Taienkang Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/FY	-- / 1.121B	--
--	2024/FY	-- / 913.930M	--
--	2023/FY	760.787M / 976.000M	--
--	2022/FY	783.480M / 858.500M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/FY-- / 1.121B--

--2024/FY-- / 913.930M--

--2023/FY760.787M / 976.000M--

--2022/FY783.480M / 858.500M--

--------

Unlock Free Earnings Estimates

Open Account

Guangdong Taienkang Pharmaceutical Earnings Reports

Taienkang: Report for the third quarter of 2024

Oct 28 12:00 ET

Taienkang: 2024 Semi-Annual Report

Aug 27 12:00 ET

Taienkang: 2024 Semi-Annual Report Summary

Aug 27 12:00 ET

Taienkang: Report for the first quarter of 2024

Apr 22 12:00 ET

Analyst Rating

Updated: Nov 3, 2024

Strong Buy

Strong Buy
100.00%
Buy
0.00%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall